For citations:

Gubar EE, Korotaeva TV, Starkova AS, Urumova MM. The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2019;13(4):79-83. (In Russ.) https://doi.org/10.14412/1996-7012-2019-4-79-83